āagman

Not investment advice. Data and computed figures, for information only.

Anthem Biosciences Ltd

NSE: ANTHEM
₹842.10
−₹5.65 (−0.67%)
NSE · 15 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹48,577 Cr
CMP
₹842.10
52-wk High / Low
₹978 / 579
P/E
81.9
P/B
15.9
Book Value
₹54.2
Div Yield
0.23%
ROCE
30.0%
ROE
22.3%
Face Value
₹2
D/E
0.02

Price+5.2% over 1Y

āagman read

Computed by āagman
Derived from 7 years and 9 quarters of filings. Not reported by the company.
As of 15 Oct 2026
How we compute these
Piotroski F-Score
7
/ 9
7 of 9 F-score tests passed
Graham Number
₹113
√(22.5 × EPS × book value per share)
ROIC
16.2%
vs 11.2% sector median
Cash flow to profit
1.43
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+75
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
18.1%
ROE × earnings retention ratio
ROE stability
4.2
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom −3.25FII +1.29DII +1.93
Latest quarter vs the previous one
Cash-accrual divergence
−8.1%
of assets
Low = accruals track cash flow
Strengths
+ROCE has stayed above the sector median for 5 consecutive years (weakest: 24% vs the 2024 sector median of 17%)
+Price trades above its 200-day moving average (1.1x)
+Piotroski F-Score of 7/9 is in the strong band (≥7)
Watch-outs

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 9 quarters
As of 30 Jun 2026
Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales339525498483540550423611418
Expenses218330338288349332266344268
Operating Profit121195160195191218157267151
OPM %35.7%37.1%32.1%40.4%35.4%39.6%37.1%43.7%36.1%
Other Income19282414234885225
Interest443123021
Depreciation192020302634354030
Profit before tax118200161178186230130278145
Net Profit821621248313617393190120
EPS (₹)1.472.902.221.482.423.091.653.382.13

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 7 years + TTM
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales6331,1031,2311,0571,4191,8452,1242,002
Expenses4516956666269141,1731,2901,209
Operating Profit182408565431506672834793
OPM %28.8%37.0%45.9%40.8%35.7%36.4%39.3%39.6%
Other Income2137491396385131133
Interest2017109101176
Depreciation626258648289134138
Profit before tax121366546497477657824783
Net Profit93271406385367451592576
EPS (₹)110.62319.74462.096.756.578.0710.5410.25

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital889114112112112—
Reserves4136931,3461,6271,8132,2982,930—
Borrowings1591003512623911354—
Other Liabilities207232228148235284333—
Total Liabilities7871,0341,6192,0142,3982,8083,429—
Fixed Assets306361329449483705783—
CWIP5019154164345297264—
Investments992092734994724331,007—
Other Assets3334458639021,0991,3731,374—
Total Assets7871,0341,6192,0142,3982,8083,429—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity166278333306140271844
Cash from Investing Activity−109−196−205−376−221−147−702
Cash from Financing Activity−48−6318164−77−136−40
Net Cash Flow918308−6−158−12103

Ratios

As of 31 Mar 2026
7 periods
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %—55.051.028.024.028.030.0
ROE %——————22.3
EPS (₹)110.62319.74462.096.756.578.0710.54
Book Value (₹)——————54.2
Face Value (₹)——————2
P/E——————81.9
Div Yield %——————0.23
NPM %14.223.831.732.224.823.426.3
OPM %29.037.046.041.036.036.039.0
D/E0.380.140.030.070.120.050.02
P/B——————15.9

Growth

As of 11 Oct 2026
Compounded sales growth
5 years+14.0%
3 years+26.0%
TTM−2.0%
Compounded profit growth
5 years+17.0%
3 years+21.0%
TTM+18.0%
Stock price CAGR
Last year+8.0%
Return on equity
5 years23.0%
3 years21.0%
Last year22.0%

Shareholding pattern

As of 31 Dec 2025
Sep 2025Dec 2025
Promoters74.67%71.42%
FIIs1.28%2.57%
DIIs11.55%13.48%
Government——
Public12.48%12.52%
No. of shareholders1,80,2201,73,273
Change since Sep 2025 (pp)
Promoters −3.25FIIs +1.29DIIs +1.93Public +0.04

Documents

As of 11 Oct 2026
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Closure of Trading WindowSettlement Of Upside Sharing ArrangementAnnouncement under Regulation 30 (LODR)-Earnings Call TranscriptShareholder Meeting / Postal Ballot-Scrutinizer''s Report
Annual reports
Annual Report 2026Annual Report 2025
Credit ratings
Rating updateRating update
Concalls
Jul 2026TranscriptJul 2026PPTJul 2026RecordingJul 2026PPTMay 2026TranscriptMay 2026PPTMay 2026RecordingFeb 2026TranscriptFeb 2026PPTFeb 2026RecordingNov 2025TranscriptNov 2025PPTNov 2025Recording

Corporate actions

As of 25 Jun 2026
25 Jun 2026DIVIDENDDividend - Rs 2 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman